Anti-angiogenic treatment of endometriosis: biochemical aspects.
article
OA: closed
CC0
⤵ 19 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper examines the biochemical mechanisms underlying anti-angiogenic therapies for endometriosis, focusing on molecular targets and treatment efficacy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (19)
- Anti-angiogenesis effect and mechanism study of Huangzhi Neiyi capsule in a rat endometriosis model 2020
- The expression of vascular endothelial growth factor is affected by hypoxia inducible factor-1α in peritoneum of endometriosis mice treated with genistein 2016
- Novel Medical Treatment Modalities of Endometriosis 2015
- Macrophage Migration Inhibitory Factor Is Involved in Ectopic Endometrial Tissue Growth and Peritoneal-Endometrial Tissue Interaction In Vivo: A Plausible Link to Endometriosis Development 2014
- Can Platelet Indices Be New Biomarkers for Severe Endometriosis? 2014
- Wenshen Xiaozheng Tang suppresses the growth of endometriosis with an antiangiogenic effect 2013
- Macrophage Migration Inhibitory Factor Antagonist Blocks the Development of Endometriosis In Vivo 2012
- Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin 2011
- Antiangiogenic agents for endometriosis 2011
- Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis 2011
- MicroRNA Signature and Regulatory Functions in the Endometrium during Normal and Disease States 2008
- Angiogenesis and antiangiogenic therapy in endometriosis 2007
- Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis 2007
- Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions 2007
- Neues zur Pathophysiologie der Endometriose 2007
- A Novel Noninvasive Model of Endometriosis for Monitoring the Efficacy of Antiangiogenic Therapy 2006
- Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model 2006
- Endostatin inhibits the growth of endometriotic lesions but does not affect fertility 2005
- Angiogenese und antiangiogene Therapien der Endometriose 2004
Source provenance
- europepmc
- last seen: 2026-08-14T06:11:53.302379+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:38.158000+00:00
License: CC0
· commercial use OK